AZD-3043

DB12576InvestigationalSmall molecule

AZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.

Chemical structure of AZD-3043
Formula / weight
C19H29NO5 · 351.443 g/mol (avg)
Code names
AZD-3043 · THRX-918661

Resolves to

Compound
UNII372AB76LQLCAS579494-66-9ChEMBLCHEMBL3354350PubChem10286834
Structure
InChIKeyQPUVKSKJCNGSGT-UHFFFAOYSA-NSMILESCCCOC(=O)CC1=CC=C(OCC(=O)N(CC)CC)C(OCC)=C1
Targets
Q99928GABRG3

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
668Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with AZD-3043, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In